Most Read Articles
Pearl Toh, 4 days ago
The combination therapy comprising carfilzomib, cyclophosphamide and dexamethasone (KCd) is effective, with a tolerable safety profile, in an Asian cohort with high-risk multiple myeloma (MM) — thus providing a more economical alternative as a potential upfront regimen in resource-limited settings, according to leading experts during a myeloma education webinar.
Audrey Abella, 20 Oct 2020
Extremes of sleep duration (≤5 or ≥10 hours/day), which is a known mortality risk factor in the general population, may increase absolute mortality in adults with type 2 diabetes (T2D), a prospective study has shown.
Pearl Toh, 21 Sep 2020
Early and sustained treatments with simplified regimen are the key to achieving good asthma control, said experts during a presentation at the ERS 2020 Congress.
Yesterday
Nocturia is a risk factor for mortality, according to the results of the Nagahama Study, which boasts of a low incidence of missing data and high representation of the general population.

NCDs continue with march in the shadow of COVID-19

Pank Jit Sin
02 Sep 2020
Tan Sri Dato' Seri Dr Noor Hisham Abdullah, Director-General of Health, MOH. (Photo credit: Corporate Communication Unit, MOH)

Director-General of Health Tan Sri Dato' Seri Dr Noor Hisham Abdullah said while things look set for recovery (as of 13 July, new COVID-19 infections were in the low double digits), he noted that the pandemic remains a threat until a specific treatment is found and an effective vaccine is produced.

“Currently, there is no clear indication of the timeline for these [to happen]. Until then, many things will never be the same again,” he said. This pandemic has transformed the world—at work or school, the international trips we used to make; the way we interact with strangers, and so on. In the meantime, the MOH continuously advises the public that they must remain cautious. He said: “The public must continue to practice the new norms in everyday life such as avoiding the 3Cs and practicing the 3Ws.”

It was also noted that the risk of serious complications and mortality due to COVID-19 increases in persons with existing health conditions such as NCDs which include type 2 diabetes mellitus, hypertension and hypercholesterolaemia. It is this reason [of comorbidities causing more severe disease in COVID-19 patients] that the NHMS 2019 findings are alarming as the rise in NCD rate within the country means that more people are at risk of severe disease should they catch the novel coronavirus. [http://www.iku.gov.my/images/IKU/Document/REPORT/NHMS2019/Fact_Sheet_NHMS_2019-English.pdf Accessed on 13 July]

Please click on the link below to access the complete article.
Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Doctor - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
Pearl Toh, 4 days ago
The combination therapy comprising carfilzomib, cyclophosphamide and dexamethasone (KCd) is effective, with a tolerable safety profile, in an Asian cohort with high-risk multiple myeloma (MM) — thus providing a more economical alternative as a potential upfront regimen in resource-limited settings, according to leading experts during a myeloma education webinar.
Audrey Abella, 20 Oct 2020
Extremes of sleep duration (≤5 or ≥10 hours/day), which is a known mortality risk factor in the general population, may increase absolute mortality in adults with type 2 diabetes (T2D), a prospective study has shown.
Pearl Toh, 21 Sep 2020
Early and sustained treatments with simplified regimen are the key to achieving good asthma control, said experts during a presentation at the ERS 2020 Congress.
Yesterday
Nocturia is a risk factor for mortality, according to the results of the Nagahama Study, which boasts of a low incidence of missing data and high representation of the general population.